Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806701 · ClinicalTrials.gov registry record · NA
Brain Response to Treatment for Pediatric PTSD
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01806701: Completed NA study, sponsored by Stanford University.
NCT01806701 is a NA study that has completed, run by Stanford University. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01806701, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
This study will examine how brain activation changes as a result of behavioral treatment for posttraumatic stress disorder (PTSD) in adolescents. The investigators will conduct functional magnetic resonance imaging (fMRI) scans before and after the widely-used trauma-focused cognitive behavioral therapy to better understand how the brain recovers from illness. This study will provide much needed information about brain abnormalities in abused youth, and could lead to improvements in behavioral treatments for patients who do not respond to current treatments.
Primary Outcome
We will use functional magnetic resonance imaging to measure changes in brain activation after 4 months of psychotherapy
Interventions
- BEHAVIORAL Trauma-focused cognitive behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT01806701 record still lists
NCT01806701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Trauma-focused cognitive behavioral therapy is the first listed.
NCT01806701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01806701 about?
NCT01806701 is a clinical study titled "Brain Response to Treatment for Pediatric PTSD". This study will examine how brain activation changes as a result of behavioral treatment for posttraumatic stress disorder (PTSD) in adolescents. The investigators will conduct functional magnetic resonance imaging (fMRI) scans before and after the widely-used trauma-focused cognitive behavioral the...
What is the current status of trial NCT01806701?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2013-04. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01806701?
The interventions under investigation include: Trauma-focused cognitive behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01806701?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01806701's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia